Tuesday, November 15, 2016
- 9:00AM-11:00AM
-
Abstract Number: 2499
Tocilizumab Achieves Rapid Reduction of Disease Activity and Has Beneficial Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events- 9:00AM-11:00AM
-
Abstract Number: 2502
Tocilizumab Therapy Reduces Corrected QT Interval in Patients with Rheumatoid Arthritis without Cardiac Symptoms
Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events- 9:00AM-11:00AM
-
Abstract Number: 2580
Tofacitinib Do Not Get Worse Subclinical Atherosclerosis Despite up-Regulating Serum Cholesterol in Methotrexate-Resistant Active Rheumatoid Arthritis Patients
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2600
Tofacitinib Is Associated with an Impaired Function of NK Cells and a Defective Immunosurveillance Against B-Cell Lymphomas
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2300
Tophaceous Gout and the Risk of Mortality: A General Population-Based Study
Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease- 9:00AM-11:00AM
-
Abstract Number: 2357
Topical Application of Aceclofenac Might NOT Produce a Significant Increase of Blood Pressure in Osteoarthritic Patients – a Continuous Automated Blood Pressure Monitor Study
Osteoarthritis – Clinical Aspects - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2196
Trajectories and Predictors of Fear-Avoidance in Persons with Rheumatoid Arthritis. a Longitudinal Observational Study
Epidemiology and Public Health - ARHP Poster- 9:00AM-11:00AM
-
Abstract Number: 2273
Trans-Ancestral Meta-Analysis Identifies Nine New Loci Associated with Serum Uric Acid Concentrations
Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease- 9:00AM-11:00AM
-
Abstract Number: 2138
Transcriptional Analysis of Synovial Tissue Reveals Sustained Inflammatory Chemokine Expression Despite Minimal Histopathologic Change in the Destabilization of Medial Meniscus Model of Murine Knee Osteoarthritis
Biology and Pathology of Bone and Joint - Poster I- 9:00AM-11:00AM
-
Abstract Number: 2455
Transcriptome Profile of Cells Isolated from a CHB Heart Support an Exuberant Inflammatory ⁄Pro-Fibrotic Cascade
Reproductive Issues in Rheumatic Disorders - Poster- 9:00AM-11:00AM
-
Abstract Number: 2426
Transcriptomic Analysis of Immune Subsets in Juvenile Dermatomyositis before and after Treatment Identifies Novel Pathways Involved in Pathogenesis
Pediatric Rheumatology – Pathogenesis and Genetics - Poster- 9:00AM-11:00AM
-
Abstract Number: 2131
Transient Receptor Potential Ankyrin 1 (TRPA1) Is Functionally Expressed in Primary Human Osteoarthritic Chondrocytes and Mediates Cartilage Destruction and Joint Pain in the Mia-Model of Osteoarthritis
Biology and Pathology of Bone and Joint - Poster I- 9:00AM-11:00AM
-
Abstract Number: 2903
Transition of Nailfold Microangiopathy throughout Different Patterns of Microvascular Damage and Correlations with Organ Involvement in Systemic Sclerosis: A Twelve Year Follow-up
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2785
Translatable in Vitro Immunocyte Functional Measures of CC-292 and CC-90008 Inhibitors of the Bruton’s Tyrosine Kinase (Btk)/Tec Family and the Pathology Observed in the MLR/Lpr Mouse Model of Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus – Animal Models - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2470
Treat to Target: Theoretical Agreement Vs Daily Applicability